Alaa Riezk

Alaa Riezk is a Research Associate at Imperial College London's Department of Infectious Disease, affiliated with the Centre for Antimicrobial Optimisation (CAMO) under the Faculty of Medicine. He holds a PhD in microbiology and drug delivery (2020) from the London School of Hygiene and Tropical Medicine and a Master's in Microbiology from Damascus University (2011). His research focuses on analytical chemistry, microbiology, pharmacology, and biomedical engineering.

• Education:
• PhD in Microbiology and Drug Delivery, London School of Hygiene and Tropical Medicine (2020)
• MSc in Microbiology, Damascus University (2011)

Technical expertise includes microbiology/immunology methods (serotyping, cell viability assays), molecular biology (PCR, NGS), imaging (confocal microscopy), and analytical techniques (HPLC). He managed a clinical lab for 3 years, overseeing quality control, diagnostic testing (e.g., Procalcitonin, C. Difficile Toxin), and drug resistance screening. His work involves in vivo studies on mice for infectious diseases and nanoparticle drug delivery.

Labs/Teams: Active in the Centre for Antimicrobial Optimisation (CAMO) and previously managed a clinical laboratory for medical testing services.